Header cover image

Australian (ASX) Pharma Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
  • 7D-3.0%
  • 3M-2.1%
  • 1Y-4.6%
  • YTD-15.8%

Over the last 7 days, the Pharma industry has dropped 3.0%, driven by a pullback from Mayne Pharma Group of 6.5%. However, the industry is down 4.6% over the past year.

Industry Valuation and Performance

Has the Australian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021AU$4.6bAU$758.4m-AU$450,516,414.0023.3x
Tue, 26 Oct 2021AU$4.8bAU$753.7m-AU$449,109,205.0024.4x
Thu, 23 Sep 2021AU$4.7bAU$753.9m-AU$445,060,581.0022.1x
Sat, 21 Aug 2021AU$4.1bAU$752.8m-AU$442,004,016.0021.1x
Sat, 05 Jun 2021AU$4.5bAU$758.8m-AU$452,149,714.0012.7x
Tue, 09 Mar 2021AU$4.8bAU$759.6m-AU$478,696,362.0071.8x
Mon, 30 Nov 2020AU$4.2bAU$761.5m-AU$402,127,165.0026.6x
Thu, 03 Sep 2020AU$4.0bAU$773.8m-AU$314,501,632.0043.1x
Sun, 07 Jun 2020AU$4.1bAU$767.4m-AU$405,897,729.0047.9x
Sat, 29 Feb 2020AU$3.6bAU$773.8m-AU$489,584,699.0022.9x
Tue, 03 Dec 2019AU$4.3bAU$792.3m-AU$452,512,211.0025.3x
Fri, 06 Sep 2019AU$4.3bAU$809.9m-AU$422,273,520.0037.5x
Mon, 10 Jun 2019AU$4.1bAU$784.7m-AU$259,069,235.0025.5x
Sun, 03 Mar 2019AU$3.3bAU$783.5m-AU$86,418,712.0025.9x
Wed, 05 Dec 2018AU$4.2bAU$752.5m-AU$192,213,841.0037.5x
PE Ratio


Total Market Cap: AU$4.2bTotal Earnings: -AU$192,213,841.00Total Revenue: AU$752.5m0%0%0%3 Year10 Year

Current Industry PE: Investors are more pessimistic on the industry, considering it's trading at a PE ratio of 23.3x which is lower than its 3-year average PE of 31.3x. It appears they believe that earnings will not grow as fast as they have historically.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years, while revenues have remained mostly flat. This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Australian Pharma industry?


Industry PE: Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 31.3x. This is likely because analysts are expecting annual earnings growth of 67%, which is higher than its past year's earnings growth of 5.6% per year.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 67% over the next 5 years. This is better than it's past earnings growth rate of 5.6% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

SPL Starpharma Holdings4.4%+AU$18.3m-16.0%PS203.6x
RNO Rhinomed12.5%+AU$7.6m54.3%PS15.5x
IXC Invex Therapeutics9.7%+AU$4.5m-15.5%PB1.6x
LGP Little Green Pharma2.3%+AU$3.5m37.4%PE6.5x
PBP Probiotec1.4%+AU$2.4m-3.2%PE32.7x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News



Cann Global